Cargando…

Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome

To gain insight into the complex microbiome-gut-brain axis in irritable bowel syndrome (IBS), several modalities of biological and clinical data must be combined. We aimed to identify profiles of fecal microbiota and metabolites associated with IBS and to delineate specific phenotypes of IBS that re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mujagic, Zlatan, Kasapi, Melpomeni, Jonkers, Daisy MAE, Garcia-Perez, Isabel, Vork, Lisa, Weerts, Zsa Zsa R.M., Serrano-Contreras, Jose Ivan, Zhernakova, Alexandra, Kurilshikov, Alexander, Scotcher, Jamie, Holmes, Elaine, Wijmenga, Cisca, Keszthelyi, Daniel, Nicholson, Jeremy K, Posma, Joram M, Masclee, Ad AM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037519/ https://www.ncbi.nlm.nih.gov/pubmed/35446234 http://dx.doi.org/10.1080/19490976.2022.2063016

Ejemplares similares

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2019)

Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients
por: Beckers, Abraham B., et al.
Publicado: (2021)

Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome
por: Snijkers, Johanna T. W., et al.
Publicado: (2021)

Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2020)

Correction: Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2021)

The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome
por: Sturkenboom, Rosel, et al.
Publicado: (2021)

Digital Instruments for Reporting of Gastrointestinal Symptoms in Clinical Trials: Comparison of End-of-Day Diaries Versus the Experience Sampling Method
por: Beckers, Abraham B, et al.
Publicado: (2021)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021)

Effect of Obesity on the Expression of Nutrient Receptors and Satiety Hormones in the Human Colon
por: Baumard, Lucas, et al.
Publicado: (2021)

A novel biomarker panel for irritable bowel syndrome and the application in the general population
por: Mujagic, Zlatan, et al.
Publicado: (2016)

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota
por: Vich Vila, Arnau, et al.
Publicado: (2020)

Does Day-to-Day Variability in Stool Consistency Link to the Fecal Microbiota Composition?
por: Vork, Lisa, et al.
Publicado: (2021)

Intestinal barrier function is maintained with aging – a comprehensive study in healthy subjects and irritable bowel syndrome patients
por: Wilms, Ellen, et al.
Publicado: (2020)

Patient-Specific Stress–Abdominal Pain Interaction in Irritable Bowel Syndrome: An Exploratory Experience Sampling Method Study
por: Vork, Lisa, et al.
Publicado: (2020)

The Experience Sampling Method—Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder
por: Vork, Lisa, et al.
Publicado: (2018)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Studying the gut virome in the metagenomic era: challenges and perspectives
por: Garmaeva, Sanzhima, et al.
Publicado: (2019)

Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia
por: van Vorstenbosch, Robert, et al.
Publicado: (2022)

Gastric peroral endoscopic pyloromyotomy for decompensated gastroparesis: comprehensive motility analysis in relation to treatment outcomes
por: Conchillo, José M., et al.
Publicado: (2021)

Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study
por: Masclee, Gwen M. C., et al.
Publicado: (2021)

The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
por: Keszthelyi, Daniel, et al.
Publicado: (2012)

Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
por: Sturkenboom, Rosel, et al.
Publicado: (2022)

Colonoscopy is safe and not associated with higher pain scores in patients with hypermobility spectrum disorder: results from an exploratory prospective study
por: Beckers, Abraham B., et al.
Publicado: (2020)

Ethanol Impairs Intestinal Barrier Function in Humans through Mitogen Activated Protein Kinase Signaling: A Combined In Vivo and In Vitro Approach
por: Elamin, Elhaseen, et al.
Publicado: (2014)

The Intestinal Barrier in Irritable Bowel Syndrome: Subtype-Specific Effects of the Systemic Compartment in an In Vitro Model
por: Ludidi, Samefko, et al.
Publicado: (2015)

Engaging transgender women in HIV research in South Africa
por: van der Merwe, L. Leigh Ann, et al.
Publicado: (2023)

Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening
por: Cheng, Hao Ran, et al.
Publicado: (2022)

Context-specific effects of genetic variants associated with autoimmune disease
por: Jonkers, Iris H., et al.
Publicado: (2017)

The MHC locus and genetic susceptibility to autoimmune and infectious diseases
por: Matzaraki, Vasiliki, et al.
Publicado: (2017)

Separation of the Origin of Ascites and Hydrothorax Fluids on the Basis of their Mucopolysaccharide Content
por: Jόzsa, Ladislas, et al.
Publicado: (1964)

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease
por: Gacesa, R., et al.
Publicado: (2021)

Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn’s disease
por: Xu, Pan, et al.
Publicado: (2021)

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2022)

Detection of stable community structures within gut microbiota co-occurrence networks from different human populations
por: Jackson, Matthew A., et al.
Publicado: (2018)

Role of the gut microbiome in mediating lactose intolerance symptoms
por: Brandao Gois, M F, et al.
Publicado: (2022)

Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics
por: Tigchelaar, Ettje F, et al.
Publicado: (2015)

Relationship between gut microbiota and circulating metabolites in population-based cohorts
por: Vojinovic, Dina, et al.
Publicado: (2019)

Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome
por: Chen, Lianmin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i7t04tjt9jcik2d30r0pttdag2